Letter: hepatitis B surface seroclearance does reduce the risk of hepatocellular carcinoma - authors' reply. [electronic resource]
- Alimentary pharmacology & therapeutics 09 2016
- 650-1 p. digital
Publication Type: Letter; Comment
1365-2036
10.1111/apt.13730 doi
Carcinoma, Hepatocellular DNA, Viral Hepatitis B Surface Antigens Hepatitis B virus--genetics Hepatitis B, Chronic Humans Liver Neoplasms